Christopher S Dahl

US Patent:

20030124569, Jul 3, 2003

Filed:

Aug 21, 2002

Appl. No.:

10/204887

Inventors:

Scott Panzer - Sunnyvale CA, US
Peter Spiro - Palo Alto CA, US
Steven Banville - Palo Alto CA, US
Purvi Shah - San Jose CA, US
Michael Chalup - Sunnyvale CA, US
Simon Chang - Mountain View CA, US
Alice Chen - San Jose CA, US
Steven D'sa - East Palo Alto CA, US
Stefan Amshey - San Francisco CA, US
Christopher Dahl - Fremont CA, US
Tam Dam - San Jose CA, US
Susan Daniels - Palo Alto CA, US
Gerard Dufour - Castro Valley CA, US
Vincent Flores - Union City CA, US
Willy Fong - San Francisco CA, US
Lila Greenawalt - San Jose CA, US
Jennifer Hillman - Mountain View CA, US
Anissa Jones - San Jose CA, US
Tommy Liu - Daly City CA, US
Ann Roseberry - Redwood City CA, US
Bruce Rosen - Menlo Park CA, US
Frank Russo - Sunnyvale CA, US
Theresa Stockdreher - Sunnyvale CA, US
Abel Daffo - San Jose CA, US
Rachel Wright - Mountain View CA, US
Pierre Yap - Lafayette CA, US
Jimmy Yu - Fremont CA, US
Diana Bradley - Soquel CA, US
Shawn Bratcher - Mountain View CA, US
Wensheng Chen - Mountain View CA, US
Howard Cohen - Palo Alto CA, US
David Hodgson - Ann Arbor MI, US
Stephen Lincoln - Redwood City CA, US

International Classification:

C12Q001/68
C07H021/02
C07H021/04
C12P019/34

US Classification:

435/006000, 435/091200, 536/023100, 536/024300

Abstract:

The present invention provides purified secretory polynucleotides (sptm). Also encompassed are the polypeptides (SPTM) encoded by sptm. The invention also provides for the use of sptm, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing sptm for the expression of SPTM. The invention additionally provides for the use of isolated and purified SPTM to induce antibodies and to screen libraries of compounds and the use of anti-SPTM antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.

US Patent:

20040048253, Mar 11, 2004

Filed:

Jun 5, 2003

Appl. No.:

10/220120

Inventors:

Scott Panzer - Sunnyvale CA, US
Peter Spiro - Palo Alto CA, US
Steven Banville - Palo Alto CA, US
Purvi Shah - San Jose CA, US
Michael Chalup - Sunnyvale CA, US
Simon Chang - Mountain View CA, US
Alice Chen - San Jose CA, US
Steven D'Sa - East Palo CA, US
Stefan Amshey - San Francisco CA, US
Christopher Dahl - Fremont CA, US
Tam Dam - San Jose CA, US
Susan Daniels - Palo Alto CA, US
Gerard Dufour - Castro Valley CA, US
Vincent Flores - Union City CA, US
Willy Fong - San Francisco CA, US
Lila Greenawalt - San Jose CA, US
Jennifer Jackson - Mountain View CA, US
Anissa Jones - San Jose CA, US
Tommy Liu - Daly City CA, US
Ann Lincoln - Redwood City CA, US
Bruce Rosen - Menlo Park CA, US
Frank Russo - Rossette Court Sunnyvale CA, US
Theresa Stockdreher - Sunnyvale CA, US
Abel Daffo - San Jose CA, US
Rachel Wright - Mountain View CA, US
Pierre Yap - Lafayette CA, US
Jimmy Yu - Fremont CA, US
Diana Bradley - Soquel CA, US
Shawn Bratcher - Mountain View CA, US
Wensheng Chen - Mountain View CA, US
Howard Cohen - Palo Alto CA, US
David Hodgson - Ann Arbor MI, US
Stephen Lincoln - Redwood City CA, US
Stuart Jackson - Mountain View CA, US

International Classification:

C12Q001/68
C07H021/04
C07K014/47
A61K038/17

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The present invention provides purified human polynucleotides for diagnostics and therapeutics (dithp). Also encompassed are the polypeptides (DITHP) encoded by dithp. The invention also provides for the use of dithp, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing dithp for the expression of DITHP. The invention additionally provides for the use of isolated and purified DITHP to induce antibodies and to screen libraries of compounds and the use of anti-DITHP antibodies in diagnostic assays. Also provided are microarrays containing dithp and methods of use.

US Patent:

20040142331, Jul 22, 2004

Filed:

Aug 11, 2003

Appl. No.:

10/363829

Inventors:

Stuart Jackson - Santa Cruz CA, US
Stephen Lincoln - Potomac MD, US
Christina Altus - Campbell CA, US
Gerard Dufour - Castro Valley CA, US
Michael Chalup - Livingston TX, US
Jennier Jackson - Santa Cruz CA, US
Anissa Jones - San Jose CA, US
Jimmy Yu - Fremont CA, US
Rachel Wright - Mountain View CA, US
Darryl Gietzen - San Jose CA, US
Tommy Liu - Daly City CA, US
Pierre Yap - Lafayette CA, US
Christopher Dahl - Longview TX, US
Monika Momiyama - Hayward CA, US
Diana Bradley - Soquel CA, US
Sameer Rohatgi - San Francisco CA, US
Bernard Harris - Sunnyvale CA, US
Ann Roseberry Lincoln - Potomac MD, US
Edward Gerstin - San Jose CA, US
Careyna Peralta - Santa Clara CA, US
Marie David - Daly City CA, US
Scott Panzer - Sunnyvale CA, US
Vincent Flores - Union City CA, US
Abel Daffo - San Jose CA, US
Rakesh Marwaha - Burnaby, CA
Alice Chen - San Jose CA, US
Simon Chang - Sunnyvale CA, US
Alan Au - Mountain View CA, US
Rebekah Inman - Mountain View CA, US

International Classification:

C12Q001/68
C07H021/04
C07K014/705

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The present invention provides purified disease detection and treatment molecule polynucleotides (mddt). Also encompassed are the polypeptides (MDDT) encoded by mddt. The invention also provides for the use of mddt, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing mddt for the expression of MDDT. The invention additionally provides for the use of isolated and purified MDDT to induce antibodies and to screen libraries of compounds and the use of anti-MDDT antibodies in diagnostic assays. Also provided are microarrays containing mddt and methods of use.

US Patent:

20050095587, May 5, 2005

Filed:

Feb 21, 2001

Appl. No.:

10/204921

Inventors:

Scott Panzer - Sunnyvale CA, US
Peter Shapiro - Berkeley CA, US
Steven Banville - Sunnyvale CA, US
Purvi Shah - San Jose CA, US
Michael Chalup - Livingston TX, US
Simon Chang - Sunnyvale CA, US
Alice Chen - San Jose CA, US
Steven D'sa - Toronto Ontario, CA
Stefan Amshey - San Francisco CA, US
Christopher Dahl - Longview TX, US
Tam Dam - San Jose CA, US
Susan Daniels - Mountain View CA, US
Gerard Dufour - Castro Valley CA, US
Vincent Flores - Union City CA, US
Willy Fong - San Francisco CA, US
Lila Greenawalt - San Jose CA, US
Jennifer Jackson - Santa Cruz CA, US
Anissa Jones - San Jose CA, US
Tommy Liu - Daly City CA, US
Ann Roseberry Lincoln - Potomac MD, US
Bruce Rosen - Menlo Park CA, US
Frank Russo - Sunnyvale CA, US
Theresa Stockdreher - Sunnyvale CA, US
Abel Daffo - San Jose CA, US
Rachel Wright - Mountain View CA, US
Pierre Yap - Lafayette CA, US
Jimmy Yu - Fremont CA, US
Diana Bradley - Soquel CA, US
Shawn Bratcher - Mountain View CA, US
Wensheng Chen - Mountain View CA, US
Howard Cohen - Palo Alto CA, US
David Hodgson - Ann Arbor MI, US
Stephen Lincoln - Potomac MD, US
Stuart Jackson - Santa Cruz CA, US

International Classification:

C12Q001/68
C07H021/04

US Classification:

435006000, 536023200

Abstract:

The present invention provides purified disease detection and treatment molecule polynucleotides (mddt). Also encompassed are the polypeptides (MDDT) encoded by mddt. The invention also provides for the use of mddt, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing mddt for the expression of MDDT. The invention additionally provides for the use of isolated and purified MDDT to induce anitbodies and to screen libraries of compounds and the use of anti-MDDT antibodies in diagnostic assays. Also provided are microarrays containing mddt and methods of use.